ORLANDO, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 13.467
EU - Europa 9.387
AS - Asia 4.781
SA - Sud America 606
OC - Oceania 118
AF - Africa 113
Continente sconosciuto - Info sul continente non disponibili 5
Totale 28.477
Nazione #
US - Stati Uniti d'America 13.353
PL - Polonia 3.284
RU - Federazione Russa 2.426
SG - Singapore 1.302
CN - Cina 1.054
HK - Hong Kong 778
SE - Svezia 661
IE - Irlanda 630
IT - Italia 619
VN - Vietnam 521
BR - Brasile 512
DE - Germania 450
KR - Corea 419
UA - Ucraina 417
FI - Finlandia 262
FR - Francia 232
IN - India 215
GB - Regno Unito 150
JO - Giordania 121
AU - Australia 114
CH - Svizzera 113
TR - Turchia 70
JP - Giappone 64
CA - Canada 50
BD - Bangladesh 44
AR - Argentina 39
ID - Indonesia 39
IQ - Iraq 38
NL - Olanda 35
MX - Messico 33
BE - Belgio 25
ZA - Sudafrica 22
AT - Austria 20
ES - Italia 20
PK - Pakistan 20
CI - Costa d'Avorio 18
SC - Seychelles 16
UZ - Uzbekistan 14
EC - Ecuador 12
NG - Nigeria 12
MA - Marocco 11
PH - Filippine 11
VE - Venezuela 11
NP - Nepal 10
PY - Paraguay 10
SA - Arabia Saudita 10
CL - Cile 9
CZ - Repubblica Ceca 8
DZ - Algeria 8
KG - Kirghizistan 7
LT - Lituania 7
AZ - Azerbaigian 6
BG - Bulgaria 6
IL - Israele 6
RO - Romania 6
CR - Costa Rica 5
EU - Europa 5
KE - Kenya 5
MY - Malesia 5
OM - Oman 5
AL - Albania 4
BJ - Benin 4
BO - Bolivia 4
KZ - Kazakistan 4
NI - Nicaragua 4
NZ - Nuova Zelanda 4
PA - Panama 4
TN - Tunisia 4
CO - Colombia 3
DO - Repubblica Dominicana 3
JM - Giamaica 3
PE - Perù 3
TH - Thailandia 3
UY - Uruguay 3
EE - Estonia 2
EG - Egitto 2
GD - Grenada 2
GR - Grecia 2
GT - Guatemala 2
KH - Cambogia 2
LV - Lettonia 2
MU - Mauritius 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TG - Togo 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CU - Cuba 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
HN - Honduras 1
IR - Iran 1
LB - Libano 1
Totale 28.465
Città #
Warsaw 3.281
Santa Clara 2.311
Ashburn 1.326
Fairfield 1.286
Singapore 905
Chandler 793
Jacksonville 686
Dublin 630
Woodbridge 627
Hong Kong 621
Seattle 516
Cambridge 499
Houston 473
San Jose 439
Wilmington 439
Seoul 417
Dallas 327
Beijing 289
Ann Arbor 249
Los Angeles 193
Buffalo 177
Princeton 172
Ho Chi Minh City 160
The Dalles 150
Altamura 148
Lauterbourg 146
Florence 143
Lawrence 143
Boardman 138
Hefei 137
Bern 112
Medford 110
Mumbai 109
Munich 107
Hanoi 106
Melbourne 103
Boston 92
New York 92
San Diego 74
Shanghai 73
Council Bluffs 70
Moscow 69
Helsinki 63
Tokyo 62
Kent 50
Izmir 48
Pune 42
São Paulo 39
Turku 39
Dong Ket 38
Norwalk 38
Milan 35
Paris 35
Auburn Hills 31
Bremen 31
Jakarta 28
Haiphong 25
Phoenix 25
Orem 24
Brussels 23
Da Nang 21
Falls Church 21
Frankfurt am Main 21
Chennai 20
Yubileyny 20
Andover 19
Abidjan 18
Toronto 18
Frankfurt Am Main 17
Hillsboro 17
Redondo Beach 17
Vienna 16
West Jordan 16
Brooklyn 15
Chicago 15
Denver 14
Redwood City 14
Tianjin 14
Baghdad 13
Clifton 12
Dhaka 12
Guangzhou 12
Johannesburg 12
London 12
Rio de Janeiro 12
Verona 12
Abuja 11
Belo Horizonte 11
Tashkent 11
Atlanta 10
Biên Hòa 10
Mexico City 10
Amsterdam 9
Lahore 9
Rome 9
Shenzhen 9
Stockholm 9
Amman 8
Ankara 8
Barnet 8
Totale 20.156
Nome #
Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers 436
A high-resolution melting protocol for rapid and accurate differential diagnosis of thyroid nodules. 369
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 367
Circulating BRAFV600E in the diagnosis and follow-up of differentiated papillary thyroid carcinoma. 355
NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis 353
BCA-1, A B-cell chemoattractant signal, is constantly expressed in cutaneous lymphoproliferative B-cell disorders. 329
High-resolution melting analysis for rapid detection of KRAS, BRAF, and PIK3CA gene mutations in colorectal cancer. 326
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 321
GALNS gene expression profiling in Morquio A patients' fibroblasts 317
Endothelin-1: a new autocrine/paracrine factor in rat testis. 316
Seladin-1 expression is regulated by promoter methylation inadrenal cancer 309
High resolution melting analysis for a rapididentification of heterozygous and homozygous sequence changes in the MUTYH gene 308
Influence of 17q gain and promoter polymorphisms on mRNA expression of somatostatin receptor type 2 in neuroblastoma. 306
Multiparametric analysis of cell-free DNA in melanoma patients. 303
Calcium-dependent activation of NF-kappa B by the adipokine resistin in hepatic stellate cells 300
STEM CELL FACTOR AFFECTS TUMOUR PROGRESSION MARKERS IN METASTATIC MELANOMA CEELS 291
Circulating cell-free DNA in plasma of melanoma patients: qualitative and quantitative considerations. 286
SPIDIA-DNA: an External Quality Assessment for the pre-analytical phase of blood samples used for DNA-based analyses. 284
Simultaneous measurement of MMP9 and TIMP1 mRNA in human non small cell lung cancers by multiplex real time RT-PCR. 277
Distribution of Tankyrase-1 mRNA expression in colon cancer and its prospective correlation with progression stage 277
Androgens regulate Phosphodiesterase type 5 expression and functional activity in corpora cavernosa 271
SPIDIA-RNA: second external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 264
Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa. 261
Prognostic value of somatostatin receptor subtype 2 expression in colorectal cancer 256
Analysis of Gene Expression Profiles Reveals Novel Correlations With the Clinical Course of Colorectal Cancer 247
Application of a filtration and isolation by size technique for the detection of circulating tumor cells in cutaneous melanoma. 242
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer. 240
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 224
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. 222
An Italian Program of External Quality Control for Quantitative Assays Based on Real-Time PCR with Taq-Man Probes. 212
Immunologically reactive albumin-like protein in human testis and seminal plasma. 211
A real-time quantitative PCR assay for the detection of Sphaeropsis sapinea from inoculated Pinus nigra shoots 210
Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer. 206
Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma 206
Allele specific Taqman–based real-time PCR assay to quantify circulating BRAFV600E mutated DNA in plasma of melanoma patients. 205
Monitoring the susceptibility to oseltamivir of Influenza A(H1N1) 2009 virus by nested-PCR and pyrosequencing during the pandemic and in the season 2010-2011. 203
ANDROGEN-RESPONSIVE AND -UNRESPONSIVE PROSTATE CANCER CELL LINES RESPOND DIFFERENTLY TO STIMULI INDUCING NEUROENDOCRINE DIFFERENTIATION 202
GM1 gangliosidosis: molecular analysis of nine patients and development of an RT-PCR assay for GLB1 gene expression profiling. 200
Persistence of expression of the TMPRSS2:ERG fusion gene afterpre-surgery androgen ablation may be associated with early prostate specific antigen relapse of prostate cancer: preliminary results. 198
Genetic and epigenetic factors in regulation of microRNA in colorectal cancers 198
null 196
[Somatostatin receptors in non-endocrine tumours]. 196
Somatostatin receptors and breast cancer 194
Adenosine triphosphate release by osmotic shock and hemoglobin A1C in diabetic subjects' erythrocytes. 191
Sertoli-germ cells interactions in the human testis 185
Tankyrase-1 mRNA expression in bladder cancer and paired urine sediment: preliminary experience. 184
SPIDIA-RNA: First external quality assessment for the pre-analytical phase of blood samples used for RNA based analyses. 184
Atypical Spitzoid melanocytic tumors: a morphological,mutational, and FISH analysis 182
Sertoli cell proteins in the human seminiferous tubule. 181
ENDOTHELIN IN RABBIT UTERUS DURING PREGNANCY. 180
Somatostatin receptor type 2 gene expression in neuroblastoma, measured by competitive RT-PCR, is related to patient survival and to somatostatin receptor imaging by indium -111-pentetreotide. 180
Natriuretic peptides exhibit specific receptors on cultured parathyroid cells linked to endothelin synthesis and release. 179
Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments. 179
Circulating tumour cells in colorectal cancer 179
Real-time PCR detection of Biscogniauxia mediterranea in symptomless oak tissue 177
Expression of Endothelin-1 gene and protein in human granulosa cells. 176
Urinary carbonic anhydrase IX splicing messenger RNA variants in urogenital cancers 176
Immunoassayable somatomedin C in seminal plasma of azoospermic men. 174
Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. 174
Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma. 174
Androgen-binding protein and other Sertoli cell proteins in human testis. 173
Circulating cell-free DNA in cancer 173
Analysis of somatostatin receptor 2 and 5 polymorphisms in patients with acromegaly. 173
Quantitative methylation analysis of BCL2, hTERT, and DAPK promoters in urine sediment for the detection of non-muscle-invasive urothelial carcinoma of the bladder: A prospective, two-center validation study. 173
Measurement of steroids in human plasma and tissues by isotope dilution mass spectrometry. 170
Characterization, regulation, and function of specific cell membrane receptors for insulin-like growth factor I on bone endothelial cells. 169
Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors. 169
Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. 168
GENE AMPLIFICATION FOR c-erbB-2, c-myc, epidermal growth factor receptor, int-2 and N-myc MEASURED BY QUANTITATIVE PCR WITH A MULTIPLE COMPETITOR TEMPLATE. 168
Neurohypophyseal hormone regulation of endothelin secretion from rabbit endometrial cells in primary culture. 168
NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis. 167
The use of COLD-PCR and High Resolution Melting Analysis improves the limit of detection of KRAS and BRAF mutations in colorectal cancer 167
Evidence for elevated telomerase activity in small cell carcinoma of the bladder. 167
BRAFV600E detection in melanoma is highlyimproved by COLD-PCR. 167
The clinical role of PIK3CA mutations in colorectal cancer 166
Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome. 166
Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer 164
Measurement of somatostatin receptor subtype 2 mRNA in breast cancer and corresponding normal tissue 164
Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. 164
Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis 163
Circulating benign nevus cells detected by ISET technique: warning for melanoma molecular diagnosis. 163
Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. 162
EQUAL-qual: a European program for external quality assessment of genomic DNA extraction and PCR amplification. 162
Analysis of 12q13-15 genes in parosteal osteosarcoma 161
Immunostaining of transferrin and transferrin receptor in human seminiferous tubules 160
Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique 160
Retrospective evaluation of c-erbB-2 oncogene amplification using competitive PCR in collecting duct carcinoma of the kidney. 160
Endothelin-1 and its receptors in human testis. 159
Steroid modulation of oxytocin/vasopressin receptors in the uterus 158
Isolation by size of epithelial tumor cells in peripheral blood of patients with breast cancer: correlation with real-time reverse transcriptase-polymerase chain reaction results and feasibility of molecular analysis by laser microdissection. 157
Rapid, quantitative nonisoptopic assay for telomerase activity in human tumors 154
Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists. 154
Up-regulated expression of low molecular weight protein tyrosine phosphatases in different human cancers 151
ATP and ADP content of human ejaculated spermatozoa. I. Relationship with semen physical parameters in normal donors and oligozoospermic patients. 151
[Fibrinolytic activity of the seminal fluid: methodological accuracy] 151
CONFIDENCE INTERVAL ESTIMATION FOR DNA AND MRNA CONCENTRATION BY REAL-TIME PCR: A NEW ENVIRONMENT FOR AN OLD THEOREM. 150
Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction. 150
Telomerase in urological malignancy 149
Transferrin and somatomedin C receptors in the human ovarian follicles 149
Comparison of pre- and postsurgical concentrations of blood HER-2 mRNA and HER-2 extracellular domain reflects HER-2 status in early breast cancer. 147
Totale 21.016
Categoria #
all - tutte 72.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021325 0 0 0 0 0 0 0 0 0 0 114 211
2021/20221.102 36 83 72 32 63 73 43 57 78 60 231 274
2022/20233.139 287 514 106 284 263 564 381 178 329 17 71 145
2023/20241.060 39 126 175 50 74 176 41 256 16 21 57 29
2024/20256.636 182 731 370 1.092 2.054 775 83 406 332 175 252 184
2025/20266.599 874 978 660 615 846 271 954 377 464 444 116 0
Totale 28.570